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SUMMARY – The aim of this study was to investigate the correlation of immunohistochemical 
expression of nm23 gene in colorectal cancer cells with tumor stage according to Dukes, tumor 
differentiation, occurrence of distant metastases and patient survival. This retrospective study in-
cluded 100 colorectal cancer patients who underwent surgical treatment. Both pathological and 
clinical data were analyzed according to sex, age, immunohistochemical expression of nm23, tumor 
stage, tumor differentiation, occurrence of distant metastases and patient survival. Overexpression 
of nm23 gene was related to both good tumor differentiation and Dukes’ stage A, whereas no si-
gnificant correlation was found between the occurrence of metastases and nm23 gene expression. 
There was no significant correlation between nm23 gene expression and 5-year survival of colorectal 
cancer patients either. Although the results of this study suggested that higher expression of nm23 
gene correlated with an early stage of tumor and its good differentiation, this parameter cannot yet 
be taken as an independent and reliable prognostic indicator in colorectal cancer. 
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Introduction
Colorectal cancer is considered to be the third 
most common malignant disease in the world in both 
sexes1,2. Colorectal cancer prognosis is strongly related 
to the stage of disease at the time of diagnosis. Clini-
cal and pathological classification of tumor according 
to Dukes is considered to be the most important indi-
cator to predict prognosis.
The level of biological aggressiveness of a tumor 
is defined by its metastatic potential. The metastatic 
process itself is a very complex process consisting of 
many steps the molecular regulation of which is still 
unknown. The change of nm23 tumor suppressor 
gene could have an important role in the metastasis 
development. The nm23 protein is normally expressed 
in the nuclei and cytoplasm of all somatic cells as well 
as on the surface of most hematopoietic cells. 
The role of nm23 gene has been examined in dif-
ferent types of tumor and the results suggest that the 
lower expression of nm23 at the protein/mRNA level 
is associated with metastatic tumors and poor progno-
sis when some types of tumors are concerned3-7. How-
ever, the role of nm23 gene in colorectal carcinoma has 
not yet been elucidated. According to some authors, a 
change of nm23 expression might be used as an im-
portant factor in prediction of the metastatic potential 
of colorectal carcinoma8-14, while other studies suggest 
that there is no statistically significant relationship of 
nm23 expression with the metastatic stage of disease 
or survival15-18.
The aim of this study was to investigate the cor-
relation of immunohistochemical expression of nm23 
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protein in colorectal cancer cells with tumor stage ac-
cording to Dukes, tumor differentiation, occurrence 
of distant metastases and patient survival.
Patients and Methods
This retrospective study included 100 colorectal 
cancer patients who underwent surgical treatment at 
University Department of Surgery, Split University 
Hospital Center in Split. Both pathological and clini-
cal data were analyzed according to sex, age, immu-
nohistochemical expression of nm23, tumor stage, tu-
mor differentiation, occurrence of distant metastases 
and patient survival. Data on distant metastases were 
obtained by regular patient follow up in surgical and 
oncologic outpatient clinics including additional di-
agnostic work-up (determination of the levels of CEA 
and Ca19.9 tumor markers, abdominal ultrasonogra-
phy and computerized tomography). Data on 5-year 
survival were obtained by inspection of the patients’ 
medical chart and by telephone or personal contact 
with the study patients and their close relatives.
Histopathologic samples were analyzed at Depart-
ment of Pathology and Cytology in the same Univer-
sity Hospital. Data used for determination of tumor 
differentiation were collected from the initial patho-
logic reports. Histologic differentiation of tumor was 
determined according to Broadman, while the origi-
nal Dukes’ classification from 1932 was used on tumor 
stage determination19. Tumor stage D was determined 
according to Astler-Coller classification20, and in the 
results it is cited as Dukes’ D stage of tumor.
The expression of nm23 in tumor epithelium was 
determined by immunohistochemistry followed by 
semi-quantitative (score 0-3) evaluation. Tissue for 
histologic analysis was fixed in 4% buffered formal-
dehyde for 24 hours and paraffin embedded. Paraf-
fin blocks were cut into slices of 3-5 micrometers and 
stained both with the standard hemalaun-eosin meth-
od and immunohistochemically using monoclonal an-
tibodies for nm23 protein (DAKO, rabbit anti human, 
AO 485 diluted 1:200). Antibodies were diluted with 
TRIS-NaCl with 1% bovine albumin 20 minutes be-
fore applying to the samples. For immunohistochemi-
cal analysis, previously deparaffinized and rehydrated 
histologic slides were heated in a microwave oven at 
750 W at temperature of 110 ºC in citrate buffer 3 
times, 5 minutes each. Then the slides were stained 
by the LSAB (streptavidin-biotin labeled) method, 
washed with distilled water and PBS and incubated 
with primary antibodies for 30 minutes in a dark hu-
mid chamber. They were washed again with PBS and 
incubated in a humid chamber at room temperature 
for 30 minutes together with binding antibody, then 
washed with PBS and incubated with chromogen di-
aminobenzidine (DAKO) in a humid chamber for 15 
minutes. They were stained using contrast hematoxy-
lin, dehydrated in ethanol gradient, cleared in xylol 
and covered with Canada balsam. Cytoplasmic stain-
ing of tumor cells was considered as positive result. 
The immunohistochemical reaction was evaluated 
by the sum of intensity and proportion of the stain. 
Negative reaction without any cytoplasmic staining of 
tumor cells was marked as 0, weak as 1, moderate as 2 
Fig. 1. Staining intensity 3-4. Fig. 1. Staining intensity 5-6.
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and intensive as 3. The proportion of staining was also 
graded from 0 to 3. Samples that had no stained cells 
were marked as 0 and those with less than 1/3 of posi-
tively stained cells as 1. The samples that contained 
between 1/3 and 2/3 of stained cells were marked as 2, 
while those with more than 2/3 of stained cells were 
marked as 3. The level of staining intensity was added 
to the level of proportion of stained cells in order to 
get a sum from 0 to 6. When there was no stain at all, 
it was marked as 0, weak reaction was marked as 1 and 
2, moderate reaction as 3 and 4 (Fig. 1), and strong 
reaction as 5 and 6 (Fig. 2). Normal colon mucosa 
stained in the same way as the study samples was used 
as a positive control, while samples where primary an-
tibody was replaced with non immune sera were used 
as a negative control.
Statistics
Student’s t-test was used to compare male and 
female patients according to age. Log-rank test was 
used to analyze patient survival. The χ2-test was used 
to compare distribution of tumor stages according to 
Dukes, histologic differentiation and the occurrence 
of distant metastases relative to immunohistochemi-
cal expression of nm23. The results were interpreted 
at the level of significance of p<0.05.
Results 
Data on 100 colorectal cancer patients were col-
lected. There were 59 (59%) female patients, mean 
age 65.9±11.5 and 41 (41%) male patients, mean age 
62.1±11.5; the male and female patients did not differ 
significantly according to age (t=1.71; p=0.090). 
Colorectal cancer patients were divided into 3 
groups according to the level of nm23 gene expression 
in cancer cells (Fig. 3). There was no statistically sig-
nificant difference between the observed and expected 
frequencies of nm23 expression in the study group of 
colorectal cancer patients (χ2=2.48; p=0.289). No type 
of nm23 gene expression was more frequent than the 
others in the group of patients with colorectal cancer 
(χ2=2.48; p=0.289).
In the study group of 100 patients, 13 (13%) 
showed a high, 32 (32%) medium and 55 (55%) low 
level of cancer differentiation.
The relation between histologic cancer differen-
tiation and nm23 gene expression was established. 
In the subgroups of patients with overexpression, hy-
poexpression and normo-expression of nm23 gene, 
there were 9 (25%), 3 (11.5%) and 1 (2.6%) patients 
with histologically well differentiated tumor, respec-
tively, and this difference was statistically significant 
(χ2=9.93; p<0.042) (Fig. 4).
A statistically significant difference was found in 
the distribution of Dukes’ tumor stages according to 
Fig. 3. Frequency of nm23 gene expression in colorectal 
cancer patients.
Fig. 4. Frequency of colorectal cancer patients according 
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the level of nm23 gene expression (χ2=13.4; p=0.037) 
(Fig. 5). The patients with Dukes’ stage A contributed 
to this difference. There were 9 (25%) such patients in 
the nm23 overexpression subgroup and 6 (9.4%) pa-
tients in the nm23 hypoexpression and nm23 normo-
expression subgroup each (χ2=4.41; p=0.036).
There was no statistically significant difference 
in the occurrence of distant metastases according to 
nm23 gene expression (χ2=0.23; p=0.891). Distant 
metastases were present in 52 and absent in 48 pa-
tients. In the nm23 gene normo-expression subgroup, 
there were 20 (52.6%) patients with and 18 (47.4%) 
patients without distant metastases (Fig. 6).
There was no statistically significant difference in 
the cumulative survival rate according to nm23 gene 
expression (Log Rank=0.74; p=0.690).
The average survival was 32, 33 and 36 months in 
the subgroups of patients with low or no nm23 ex-
pression, nm23 normo-expression and nm23 overex-
pression, respectively. The probability of 5-year sur-
vival was 43% in the subgroup of patients with low or 
no nm23 expression, 40% in the subgroup with nm23 
normo-expression and 47% in the subgroup with 
nm23 overexpression (Fig. 7).
Discussion
Colorectal cancer is considered as one of the most 
common types of cancer in humans and its frequency 
is constantly rising. The prognosis of colorectal cancer 
patients is closely related to the depth of penetration 
to the intestine wall as well as to the presence of re-
gional lymph nodes and distant metastases. 
The level of biological aggressiveness of a tumor is 
defined by its metastatic potential and the occurrence 
of distant metastases is the final result of tumor pro-
gression, which is the most common reason for un-
successful treatment. Therefore, great effort is made 
to discover genes that are involved in the metastatic 
process. Identification of such genes, able to enhance 
or inhibit metastatic phenotype in primary tumor, 
Fig. 5. Frequency of colorectal cancer patients according to 
Dukes’ stage and nm23 gene expression.
Fig. 6. Frequency of colorectal cancer patients according 
to the occurrence of distant metastases and nm23 gene ex-
pression.
Fig. 7. Survival rate in colorectal cancer patients according 
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would be of great importance for prognosis and ther-
apy. Some researches have shown that variations in 
nm23 gene might influence the occurrence of metas-
tases. In 1988, Steeg et al. showed that nm23 gene ex-
pression was considerably lower in tumors with high 
metastatic potential comparing to tumors with low 
metastatic potential21, and since then nm23 gene has 
been considered as a possible tumor suppressor gene. 
Nevertheless, the results of various researches are not 
uniform, so reduced expression of nm23 gene has 
been related to the occurrence of metastasis and worse 
prognosis of breast cancer3,22-25, hepatocellular can-
cers4,26, malignant melanoma27, and gastric cancer28, 
while at the same time the situation is completely op-
posite in case of pancreas cancer29, adenocarcinoma of 
the lung30, and neuroblastoma31.
The role of nm23 gene has not yet been elucidated 
when colorectal cancer is concerned. According to 
some studies8-14, a change in nm23 gene expression 
can be used as an important indicator for prognosis 
of metastatic potential, whereas other researchers15-18 
claim that there is no significant relation between nm 
23 expression and the occurrence of metastasis.
In this study, the change in nm23 gene expression 
in primary colon carcinoma was investigated in rela-
tion to normal colon mucosa, and there was no differ-
ence in the level of nm23 expression in the analyzed 
samples. Nevertheless, it was found that overexpres-
sion of nm23 gene correlated with both good tumor 
differentiation and Dukes’ A stage. Furthermore, 
there was no significant correlation of nm23 gene ex-
pression with the occurrence of metastasis and 5-year 
survival of colorectal cancer patients. 
The results of this study indicated that nm23 gene 
could be involved in the control of metastatic poten-
tial of a tumor in its early stage, when histologically 
well differentiated tumors are concerned. The correla-
tion of nm23 gene overexpression with both clinical 
stage (Dukes’ A) and good differentiation of a tumor 
is suggesting the possible protective role of nm23 gene 
in the early process of tumorigenesis. It is possible 
that, in later phases of tumor progression, the effect 
of nm23 gene is suppressed by other oncogenes and 
tumor suppressor genes that stimulate more malig-
nant phenotypes characterized by weaker differentia-
tion, higher invasive ability and metastatic activity of 
tumor cells. Furthermore, nm23 gene might be one 
of the factors responsible for the prevention of early 
stages of metastasis formation, since it was found that 
it was able to stop motility and colonization in the 
cultures of melanoma and breast cancer cells32,33. Fi-
nally, according to the results of this study, it can be 
concluded that there is a correlation between higher 
expression of nm23 gene and the early stage of tumor 
as well as its good differentiation, but it still cannot be 
taken as an independent and reliable prognostic indi-
cator when colorectal cancer is concerned. For such a 
finding, additional studies including more colorectal 
cancer patients are necessary.
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Sažetak
ULOGA GENA nm23 U KOLOREKTALNOM KARCINOMU 
A. Tripković, I. Tripković, S. Tomić, A. Kovačić, L. Grandić i V. Čapkun
Cilj ovoga rada bio je istražiti povezanost između promjene ekspresije gena nm23 u stanicama kolorektalnog karcino-
ma sa stadijem tumora po Dukesu, diferenciranosti tumora, pojavom udaljenih metastaza i petogodišnjim preživljenjem. U 
ovom istraživanju obrađeno je 100 bolesnika oboljelih od karcinoma debelog crijeva koji su operirani u Klinici za kirurgiju 
KBC Split. Patohistološki i klinički podaci analizirani su prema spolu, dobi, imunohistokemijskoj ekspresiji gena nm23, 
stadiju tumora po Dukesu, stupnju histološke diferenciranosti tumora, pojavi udaljenih metastaza i petogodišnjem preživ-
ljenju. Utvrđeno je da dobro diferencirani karcinomi pokazuju statistički značajnu prekomjernu ekspresiju gena nm23. Isto 
tako, nađena je prekomjerna ekspresija gena nm23 u stadiju tumora Dukes A. Nije nađena povezanost između promjene 
ekspresije gena nm23 i pojave udaljenih metastaza ni petogodišnjeg preživljenja. Promjena ekspresije gena nm23, prema 
rezultatima ovoga istraživanja, ne može se rabiti za predviđanje pojave metastaza i procjenu petogodišnjeg preživljenja, ali 
povezanost prekomjerne ekspresije gena nm23 s ranim kliničkim stadijem (Dukes A) i dobrom diferencijacijom tumora 
upućuje na mogućnost zaštitnog djelovanja gena nm23 u ranom procesu tumorigeneze. 
Ključne riječi: Kolorektalni karcinom; gen nm23; Geni tumorske supresije; Stadij tumora po Dukesu; Metastaze

